A Comparativel in Vitro Metabolic Study of Methaphenilene and Pyribenzamine

References

• Althaus F. R., Lawrence S. D., Sattler G. L., Pitot H. C. DNA damage induced by the antihistaminic drug methapyrilene hydrochloride. Mutation Research 1982; 103: 213–218
   PubMed Web of Science ®Google Scholar
• Brennan L. M., Creasia D. A. The effects of methapyrilene hydrochloride on hepatocarcinogenicity and pentobarbitol‐induced sleeping time in rats and mice. Toxicology and Applied Pharmacology 1982; 66: 252–258
   PubMed Web of Science ®Google Scholar
• Budroe J. D., Shaddock J. G., Casciano D. A. A study of the potential genotoxicity of methapyrilene and related antihistamines using the hepatocyte/DNA repair assay. Mutation Research 1984; 135: 131–137
   PubMed Web of Science ®Google Scholar
• Chambon P., Mougenot R. Research into an N‐oxide metabolite: experiments with tripelennamine (pyribenzamine) hydrochloride. Comptu Rendu Academic Sciences Paris 1969; 268: 596–598
   PubMedGoogle Scholar
• Chaudhuri N. K., Servando O. A., Manniello M. J., Luders R. C., Chao D. K., Bartlett M. F. Metabolism of tripelennamine in man. Drug Metabolism and Disposition 1976; 4: 372–378
   PubMed Web of Science ®Google Scholar
• Habs M., Shubik P., Eisenbrand G. Carcinogenicity of methapyrilene hydrochloride, thenyldiamine hydrochloride, and pyribenzamine hydrochloride in Sprague‐Dawley rats. Journal of Cancer Research and Clinical Oncology 1986; 111: 71–74
   PubMed Web of Science ®Google Scholar
• Iype P. T., Ray‐Chauduri R., Lijinsky W., Kelley S. P. Inability of methapyrilene to induce sister‐chromatid exchanges in vitro and, in vivo. Cancer Research 1982; 42: 4614–4618
   PubMed Web of Science ®Google Scholar
• Kammerer R. C., Lampe M. A. In vitro metabolism of chlorpheniramine in the rabbit. Biochemical Pharmacology 1987; 36: 3445–3452
   PubMed Web of Science ®Google Scholar
• Kammerer R. C., Schmitz D. A. Metabolism of methapyrilene by rat liver homogenate. Xenobiotica 1986; 16: 671–680
   PubMed Web of Science ®Google Scholar
• Kammerer R. C., Schmitz D. A. Species differences in the metabolism of the carcinogen methapyrilene. Xenobiotica 1987a; 17: 1121–1130
   PubMed Web of Science ®Google Scholar
• Kammerer R. C., Schmitz D. A. The comparative metabolism of pyribenzamine and methapyrilene. The Pharmacologist 1987b; 29: 177
   Google Scholar
• Kammerer R. C., Schmitz D. A. The comparative metabolism of methaphenilene and methapyrilene. ISSX‐SOT Meeting, Clearwater. November, 8–131987c. , Florida
   Google Scholar
• Kammerer R. C., Froines J. R., Price T. Mutagenicity studies of selected antihistamines, their metabolites and products of nitrosation. Food and Chemical Toxicology 1986; 24: 981–985
   PubMed Web of Science ®Google Scholar
• Kammerer R. C., Kloc K. Synthesis of a deuterium labeled variant of the rat hepatocarcinogen, methapyrilene. Journal of Labeled Compounds and Radiopharmaceuticals 1987; 24: 1469–1477
   Web of Science ®Google Scholar
• Kammerer R. C., Kloc K., Lampe M. A., Schmitz D. A. Oxidation of the pyridine ring: a major pathway of metabolism for the rat hepatocarcinogen, methapyrilene. Proceedings of the Western Pharmacology Society 1987; 30: 79–83
   PubMedGoogle Scholar
• Kammerer R. C., Schmitz D. A., Lampe M., Kloc K. The in vivo metabolism of methapyrilene, a hepatocarcinogen, in the rat. Xenobiotica 1988; 18: 873–886
   Web of Science ®Google Scholar
• Lampe M. A., Kammerer R. C. The effect of chronic methapyrilene treatment on methapyrilene metabolism in vitro. Carcinogenesis 1987a; 8: 221–226
   PubMed Web of Science ®Google Scholar
• Lampe M. A., Kammerer R. C. Cytochrome P‐450 dependent binding of methapyrilene to DNA in vitro. Carcinogenesis 1987b; 8: 1525–1529
   PubMed Web of Science ®Google Scholar
• Lijinsky W., Reuber M. D., Blackwell B. N. Liver tumors induced by oral administration of the antihistamine methapyrilene hydrochloride. Science 1980; 209: 817–819
   PubMed Web of Science ®Google Scholar
• Lijinsky W., Knutsen G., Reuber M. D. Failure of methapyrilene to induce tumors in hamsters or guinea pigs. Journal of Toxicology and Environmental Health 1983; 12: 653–657
   PubMed Web of Science ®Google Scholar
• Lijinsky W. Chronic toxicity tests of pyrilamine maleate and methapyrilene hydrochloride in F344 rats. Food and Chemical Toxicology 1984; 22: 27–30
   PubMed Web of Science ®Google Scholar
• Lijinsky W., Kovatch R. M. Carcinogenicity studies of some analogs of the carcinogen, methapyrilene, in F344 rats. Journal of Cancer Research and Clinical Oncology 1986; 112: 57–60
   PubMed Web of Science ®Google Scholar
• Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• McQueen C. A., Williams G. M. Characterization of DNA repair elicited by carcinogens and drugs in the hepatocyte primary culture/DNA repair test. Journal of Toxicology and Environmental Health 1981; 8: 463–477
   PubMed Web of Science ®Google Scholar
• Omura T., Sato R. The carbon monoxide binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. Journal of Biological Chemistry 1964; 239: 2370–2378
   PubMed Web of Science ®Google Scholar
• Probst G. S., Neal S. B. The induction of unscheduled DNA synthesis by antihistamines in primary hepatocyte cultures. Cancer Letters 1980; 10: 67–73
   PubMed Web of Science ®Google Scholar
• Rao G. S., Krishna G., Gillette J. R. Metabolism, tissue distribution and covalent binding of tripelennamine and its N‐nitioso derivative in the rat. Journal of Pharmacology and Experimental Therapeutics 1975; 195: 433–440
   PubMed Web of Science ®Google Scholar
• Steinmetz K. L., Tyson C. K., Meierhenry E. J., Spalding J. W., Mirsalis J. C. Examination of genotoxicity, toxicity, and morphologic alterations in hepatocytes following in vivo or in vitro exposure to methapyrilene. Carcinogenesis 1988; 9: 959–963
   PubMed Web of Science ®Google Scholar
• Turner N. T., Woolley J. L., Jr., Hozier J. C., Sawyer J. R., Clive D. Methapyrilene is a genotoxic carcinogen: studies on methapyrilene and pyrilamine in the L5178Y/TK+/‐ mouse lymphoma assay. Mutation Research 1987; 189: 285–297
   PubMed Web of Science ®Google Scholar
• Underwood B., Lijinsky W. Metabolism of the liver carcinogen methapyrilene. American Association for Cancer Research Annual Meeting. 1980; 133, Abstracts No. 454
   Google Scholar
• Weinman E. O., Geissman T. A. The distribution, excretion and metabolism of C14‐labeled tripelennamine (pyribenzamine) by guinea pigs. Journal of Pharmacology and Experimental Therapeutics 1959; 125: 1–13
   PubMed Web of Science ®Google Scholar
• Yeh S. Y. N‐Debenzylation of pyrilamine and tripelennamine in the rat. A new metabolic pathway. Drug Metabolism and Disposition 1987; 15: 466–472
   PubMed Web of Science ®Google Scholar
• Yeh S. Y., Hsu F. L. Quantitative metabolic profile of tripelennamine and pyrilamine in the rat. Drug Metabolism and Disposition 1988; 16: 499–502
   PubMed Web of Science ®Google Scholar
• Ziegler R., Ho B., Castagnoli N., Jr. Trapping of metabolically generated electrophilic species with cyanide ion: metabolism of methapyrilene. Journal of Medicinal Chemistry 1981; 24: 1133–1138
   PubMed Web of Science ®Google Scholar